Inventor · disambiguated record
Avner Yayon
Also filed as: YAYON AVNER
32 granted patents·17 pending applications·2,061 citations·filing 1990–2018
97Inventor score
Top patents by PatentIndex Score
49 records- 0197US7009039B2Plasma protein matrices and methods for their preparationPROCHON BIOTECH LTD·Filed 2004·Granted Mar 7, 2006·1.4k cites·53 claims
- 0294US7276481B2Method and composition for treatment of skeletal dysplasiasPROCHON BIOTECH LTD·Filed 2003·Granted Oct 2, 2007·91 cites·30 claims
- 0393US7563769B2FGF variants and methods for use thereofPROCHON BIOTECH LTD·Filed 2004·Granted Jul 21, 2009·54 cites·35 claims
- 0493US7288406B2Active variants of FGF with improved specificityPROCHON BIOTECH LTD·Filed 2003·Granted Oct 30, 2007·109 cites·22 claims
- 0590US7335508B2Porous plasma protein matrices and methods for preparation thereofPROCHON BIOTECH LTD·Filed 2004·Granted Feb 26, 2008·46 cites·35 claims
- 0689US8101721B2Antibodies blocking fibroblast growth factor receptor activation and methods of use thereofYAYON AVNER·Filed 2007·Granted Jan 24, 2012·14 cites·16 claims
- 0789US7498416B2Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereofFIBRON LTD·Filed 2003·Granted Mar 3, 2009·52 cites·6 claims
- 0888US8916522B2FGF-9 variants and methods of use thereofPROCHON BIOTECH LTD·Filed 2013·Granted Dec 23, 2014·4 cites·5 claims
- 0987US8193317B2Freeze-dried fibrin matrices and methods for preparation thereofYAYON AVNER·Filed 2010·Granted Jun 5, 2012·7 cites·12 claims
- 1086US8962556B2FGF-2 variants having N-terminal deletions and increased receptor selectivity and uses thereofYAYON AVNER·Filed 2007·Granted Feb 24, 2015·15 cites·8 claims
- 1186US8828385B2Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereofYAYON AVNER·Filed 2009·Granted Sep 9, 2014·9 cites·8 claims
- 1285US7714107B2Freeze-dried fibrin matrices and methods for preparation thereofPROCHON BIOTECH LTD·Filed 2005·Granted May 11, 2010·6 cites·16 claims
- 1385US5491220ASurface loop structural analogues of fibroblast growth factorsYEDA RES & DEV·Filed 1994·Granted Feb 13, 1996·71 cites·9 claims
- 1481US8119783B2FGF variants and methods for use thereofBOGIN OREN·Filed 2009·Granted Feb 21, 2012·3 cites·6 claims
- 1579US8618258B2Freeze-dried fibrin matrices and methods for preparation thereofYAYON AVNER·Filed 2012·Granted Dec 31, 2013·4 cites·20 claims
- 1679US7887831B2Bone enhancing compositePROCHON BIOTECH LTD·Filed 2003·Granted Feb 15, 2011·8 cites·32 claims
- 1778US9226949B2FGF-18 truncated variants having increased receptor specificity and uses thereofHEPACORE LTD·Filed 2013·Granted Jan 5, 2016·5 cites·20 claims
- 1876US6517872B1FGFR3 as a marker for mesenchymal skeletal progenitor cellsYEDA RES & DEV·Filed 1996·Granted Feb 11, 2003·43 cites·10 claims
- 1975US7264946B2Thermoanaerobacter brockii alcohol dehydrogenase promoter for expression of heterologous proteinsYEDA RES & DEV·Filed 2003·Granted Sep 4, 2007·5 cites·9 claims
- 2074US5789182ASystem for assaying binding to a heparin-binding growth factor receptorCHILDRENS MEDICAL CENTER·Filed 1993·Granted Aug 4, 1998·33 cites·28 claims
- 2170US9487568B2FGF-2 variants and methods of use thereofPROCHON BIOTECH LTD·Filed 2014·Granted Nov 8, 2016·0 cites·19 claims
- 2269US2008194682A1Method and composition for treatment of skeletal dysplasiasPROCHON BIOTECH LTD·Filed 2007·Application pending·0 cites
- 2366US2014271868A1Treatment of achondroplasia with encapsulated cnp-secreting cellsHEPACORE LTD·Filed 2014·Application pending·0 cites
- 2465US9610357B2Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereofHEPACORE LTD·Filed 2013·Granted Apr 4, 2017·1 cites·8 claims
- 2565US6265632B1Animal model for fibroblast growth factor receptor associated chondrodysplasiaYEDA RES & DEV·Filed 1999·Granted Jul 24, 2001·24 cites·9 claims
- 2663US8329870B2Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereofAMIT BOAZ·Filed 2008·Granted Dec 11, 2012·1 cites·29 claims
- 2762US2017095533A1FGF-9 Variants and Methods of Use ThereofPROCHON BIOTECH LTD·Filed 2016·Application pending·0 cites
- 2860US8609823B2FGF-9 variants and methods for use thereofBOGIN OREN·Filed 2012·Granted Dec 17, 2013·0 cites·13 claims
- 2959US6447783B1Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repairYEDA RES & DEV·Filed 1996·Granted Sep 10, 2002·12 cites·7 claims
- 3054US2012328699A1Method and composition for treatment of skeletal dysplasiasGOLEMBO MYRIAM·Filed 2011·Application pending·0 cites
- 3152US8940888B2Hydrazido derivatives of hyaluronic acidPROCHON BIOTECH LTD·Filed 2013·Granted Jan 27, 2015·0 cites·14 claims
- 3250US2018127475A1Fgf-2 variants having n-terminal deletions and increased receptor selectivity and uses thereofPROCHON BIOTECH LTD·Filed 2017·Application pending·0 cites
- 3349US8524885B2Hydrazido derivatives of hyaluronic acidAMIT BOAZ·Filed 2007·Granted Sep 3, 2013·0 cites·16 claims
- 3449US2020223927A1Methods and compositions for treating multiple sclerosisYAYON AVNER·Filed 2018·Application pending·0 cites
- 3548US5270197ACells expressing a substantial number of surface high affinity HBGF receptors but relatively few low affinity HBGF binding sites and system for assaying binding to HBGF receptorCHILDRENS MEDICAL CENTER·Filed 1990·Granted Dec 14, 1993·11 cites·9 claims
- 3648US2004014024A1Screening assay for antagonists of FGFR-mediated malignant cell transformation and tumor formationFiled 2001·Application pending·0 cites
- 3748US2002193309A1FGF9 as a specific ligand for FGFR3YEDA RES AND DEV CO LTD AN ISR·Filed 2002·Application pending·0 cites
- 3847US9862753B2FGF-2 variants having N-terminal deletions and increased receptor selectivity and methods of use thereofPROCHON BIOTECH LTD·Filed 2015·Granted Jan 9, 2018·0 cites·7 claims
- 3947US6730666B1Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivativesYEDA RES & DEV·Filed 1999·Granted May 4, 2004·15 cites·34 claims
- 4046US8298528B2Methods for bone regeneration using endothelial progenitor cell preparationsYAYON AVNER·Filed 2007·Granted Oct 30, 2012·0 cites·16 claims
- 4146US2003100492A1Proteoglycans and pharmaceutical compositions comprising themFiled 2000·Application pending·0 cites
- 4246US2005054560A1Cd44 variants carrying heparan sulfate chains and uses thereofYISSUM RES DEV CO·Filed 2002·Application pending·0 cites
- 4345US2009155229A1Chondrocyte-based implant for the delivery of therapeutic agentsYAYON AVNER·Filed 2005·Application pending·0 cites
- 4445US2008044419A1Treatment of T Cell Mediated Diseases by Inhibition of Fgfr3FIBRON LTD·Filed 2004·Application pending·0 cites
- 4544US2003206912A1FGFR3 as a marker for mesenchymal skeletal progenitor cellsYEDA RES & DEV·Filed 2002·Application pending·0 cites
- 4642US2017196986A1Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereofHEPACORE LTD·Filed 2017·Application pending·0 cites
- 4738US2010274362A1Cartilage particle tissue mixtures optionally combined with a cancellous constructYAYON AVNER·Filed 2010·Application pending·0 cites
- 4838US2013084278A1Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereofHEPACORE LTD·Filed 2012·Application pending·0 cites
- 4938US2009175866A1Treatment of b-cell malignanciesYAYON AVNER·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →